Abstract
CARD subfamily is the second largest subfamily in the DD superfamily that plays important roles in regulating various signaling pathways, including but not limited to NF-kB activation signaling, apoptosis signaling and inflammatory signaling. The CARD subfamily contains 33 human CARD-containing proteins, regulating the assembly of many signaling complexes, including apoptosome, inflammsome, nodosome, the CBM complex, PIDDosome, the TRAF2 complex, and the MAVS signalosome, by homotypic CARD–CARD interactions. The mechanism of how CARDs find the right binding partner to form a specific complex remains unclear. This review uses different classification schemes to update the classification of CARD-containing proteins. Combining the classification based on domain structures, functions, associated signaling complexes, and roles would help better understand the structural and function diversity of CARD-containing proteins. This review also summarizes recent structural studies on CARDs. Especially, the CARD-containing complexes can be divided into the homodimeric, heterodimeric, oligomeric, filamentous CARD complexes and the CARD–ubiquitin complex. This review will give an overview of the versatile roles of CARDs in regulating signaling transduction, as well as the therapeutic drugs targeting CARD-containing proteins.
Similar content being viewed by others
References
Haanen C, Vermes I (1995) Apoptosis and inflammation. Mediators Inflamm 4:5–15. doi:10.1155/S0962935195000020
Park HH, Lo YC, Lin SC, Wang L, Yang JK, Wu H (2007) The death domain superfamily in intracellular signaling of apoptosis and inflammation. Annu Rev Immunol 25:561–586. doi:10.1146/annurev.immunol.25.022106.141656
Joshi VD, Kalvakolanu DV, Cross AS (2003) Simultaneous activation of apoptosis and inflammation in pathogenesis of septic shock: a hypothesis. FEBS Lett 555:180–184
Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239–257
Duvall E, Wyllie AH (1986) Death and the Cell. Immunol Today 7:115–119. doi:10.1016/0167-5699(86)90152-0
Salvesen GS (2002) Caspases and apoptosis. Essays Biochem 38:9–19
Riedl SJ, Shi Y (2004) Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5:897–907. doi:10.1038/nrm1496
Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267:1456–1462
Fernald K, Kurokawa M (2013) Evading apoptosis in cancer. Trends Cell Biol 23:620–633. doi:10.1016/j.tcb.2013.07.006
Tait SW, Green DR (2010) Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11:621–632. doi:10.1038/nrm2952
Lomonosova E, Chinnadurai G (2008) BH3-only proteins in apoptosis and beyond: an overview. Oncogene 27(1):S2–S19. doi:10.1038/onc.2009.39
Tait SW, Green DR (2013) Mitochondrial regulation of cell death. Cold Spring Harb perspect biol. doi:10.1101/cshperspect.a008706
Moldoveanu T, Follis AV, Kriwacki RW, Green DR (2014) Many players in BCL-2 family affairs. Trends Biochem Sci 39:101–111. doi:10.1016/j.tibs.2013.12.006
Bao Q, Shi Y (2007) Apoptosome: a platform for the activation of initiator caspases. Cell Death Differ 14:56–65. doi:10.1038/sj.cdd.4402028
Shi Y (2006) Mechanical aspects of apoptosome assembly. Curr Opin Cell Biol 18:677–684. doi:10.1016/j.ceb.2006.09.006
Riedl SJ, Salvesen GS (2007) The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 8:405–413. doi:10.1038/nrm2153
Silke J, Meier P (2013) Inhibitor of apoptosis (IAP) proteins-modulators of cell death and inflammation. Cold Spring Harbor perspectives in biology. doi:10.1101/cshperspect.a008730
Sessler T, Healy S, Samali A, Szegezdi E (2013) Structural determinants of DISC function: new insights into death receptor-mediated apoptosis signalling. Pharmacol Ther 140:186–199. doi:10.1016/j.pharmthera.2013.06.009
Lavrik I, Golks A, Krammer PH (2005) Death receptor signaling. J Cell Sci 118:265–267. doi:10.1242/jcs.01610
Park SM, Schickel R, Peter ME (2005) Nonapoptotic functions of FADD-binding death receptors and their signaling molecules. Curr Opin Cell Biol 17:610–616. doi:10.1016/j.ceb.2005.09.010
Reed JC, Doctor KS, Godzik A (2004) The domains of apoptosis: a genomics perspective. Sci STKE. doi:10.1126/stke.2392004re9
Kersse K, Verspurten J, Vanden Berghe T, Vandenabeele P (2011) The death-fold superfamily of homotypic interaction motifs. Trends Biochem Sci 36:541–552. doi:10.1016/j.tibs.2011.06.006
Qin H, Srinivasula SM, Wu G, Fernandes-Alnemri T, Alnemri ES, Shi Y (1999) Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1. Nature 399:549–557. doi:10.1038/21124
Xiao T, Towb P, Wasserman SA, Sprang SR (1999) Three-dimensional structure of a complex between the death domains of Pelle and Tube. Cell 99:545–555
Park HH, Logette E, Raunser S et al (2007) Death domain assembly mechanism revealed by crystal structure of the oligomeric PIDDosome core complex. Cell 128:533–546. doi:10.1016/j.cell.2007.01.019
Lin SC, Lo YC, Wu H (2010) Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 465:885–890. doi:10.1038/nature09121
Scott FL, Stec B, Pop C et al (2009) The Fas-FADD death domain complex structure unravels signalling by receptor clustering. Nature 457:1019–1022. doi:10.1038/nature07606
Wang L, Yang JK, Kabaleeswaran V et al (2010) The Fas-FADD death domain complex structure reveals the basis of DISC assembly and disease mutations. Nat Struct Mol Biol 17:1324–1329. doi:10.1038/nsmb.1920
Wu B, Peisley A, Tetrault D et al (2014) Molecular Imprinting as a Signal-Activation Mechanism of the Viral RNA Sensor RIG-I. Mol Cell 55:511–523. doi:10.1016/j.molcel.2014.06.010
Adrain C, Martin SJ (2001) The mitochondrial apoptosome: a killer unleashed by the cytochrome seas. Trends Biochem Sci 26:390–397
Hong GS, Jung YK (2002) Caspase recruitment domain (CARD) as a bi-functional switch of caspase regulation and NF-kappaB signals. J Biochem Mol Biol 35:19–23
Jiang C, Lin X (2012) Regulation of NF-kappaB by the CARD proteins. Immunol Rev 246:141–153. doi:10.1111/j.1600-065X.2012.01110.x
Kwon D, Yoon JH, Shin SY et al (2012) A comprehensive manually curated protein-protein interaction database for the Death Domain superfamily. Nucleic Acids Res 40:D331–D336. doi:10.1093/nar/gkr1149
Bouchier-Hayes L, Martin SJ (2002) CARD games in apoptosis and immunity. EMBO Rep 3:616–621. doi:10.1093/embo-reports/kvf139
Kufer TA, Sansonetti PJ (2011) NLR functions beyond pathogen recognition. Nat Immunol 12:121–128. doi:10.1038/ni.1985
Rawlings DJ, Sommer K, Moreno-Garcia ME (2006) The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes. Nat Rev Immunol 6:799–812. doi:10.1038/nri1944
Blonska M, Lin X (2011) NF-kappaB signaling pathways regulated by CARMA family of scaffold proteins. Cell Res 21:55–70. doi:10.1038/cr.2010.182
Lopez J, John SW, Tenev T et al (2011) CARD-mediated autoinhibition of cIAP1′s E3 ligase activity suppresses cell proliferation and migration. Mol Cell 42:569–583. doi:10.1016/j.molcel.2011.04.008
Gyrd-Hansen M, Meier P (2010) IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat Rev Cancer 10:561–574. doi:10.1038/nrc2889
Maelfait J, Beyaert R (2012) Emerging role of ubiquitination in antiviral RIG-I signaling. Microbiol Mol Biol Rev 76:33–45. doi:10.1128/MMBR.05012-11
O’Neill LA, Bowie AG (2011) The powerstroke and camshaft of the RIG-I antiviral RNA detection machine. Cell 147:259–261. doi:10.1016/j.cell.2011.09.027
Tschopp J, Schroder K (2010) NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 10:210–215. doi:10.1038/nri2725
Yuan S, Yu X, Asara JM, Heuser JE, Ludtke SJ, Akey CW (2011) The holo-apoptosome: activation of procaspase-9 and interactions with caspase-3. Structure 19:1084–1096. doi:10.1016/j.str.2011.07.001
Bouchier-Hayes L, Green DR (2012) Caspase-2: the orphan caspase. Cell Death Differ 19:51–57. doi:10.1038/cdd.2011.157
Moreira LO, Zamboni DS (2012) NOD1 and NOD2 signaling in infection and inflammation. Front Immunol 3:328. doi:10.3389/fimmu.2012.00328
Thome M, Charton JE, Pelzer C, Hailfinger S (2010) Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1. Cold Spring Harb Perspect Biol 2:a003004. doi:10.1101/cshperspect.a003004
Woo HN, Hong GS, Jun JI et al (2004) Inhibition of Bcl10-mediated activation of NF-kappa B by BinCARD, a Bcl10-interacting CARD protein. FEBS Lett 578:239–244
Lee SH, Stehlik C, Reed JC (2001) Cop, a caspase recruitment domain-containing protein and inhibitor of caspase-1 activation processing. J Biol Chem 276:34495–34500. doi:10.1074/jbc.M101415200
Lamkanfi M, Denecker G, Kalai M et al (2004) INCA, a novel human caspase recruitment domain protein that inhibits interleukin-1beta generation. J Biol Chem 279:51729–51738. doi:10.1074/jbc.M407891200
Druilhe A, Srinivasula SM, Razmara M, Ahmad M, Alnemri ES (2001) Regulation of IL-1beta generation by Pseudo-ICE and ICEBERG, two dominant negative caspase recruitment domain proteins. Cell Death Differ 8:649–657. doi:10.1038/sj.cdd.4400881
Le HT, Harton JA (2013) Pyrin- and CARD-only proteins as regulators of NLR functions. Front Immunol 4:275. doi:10.3389/fimmu.2013.00275
Koseki T, Inohara N, Chen S, Nunez G (1998) ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proc Natl Acad Sci USA 95:5156–5160
Nam YJ, Mani K, Ashton AW et al (2004) Inhibition of both the extrinsic and intrinsic death pathways through nonhomotypic death-fold interactions. Mol Cell 15:901–912. doi:10.1016/j.molcel.2004.08.020
Dufner A, Pownall S, Mak TW (2006) Caspase recruitment domain protein 6 is a microtubule-interacting protein that positively modulates NF-kappaB activation. Proc Natl Acad Sci USA 103:988–993. doi:10.1073/pnas.0510380103
Zhu S, Jackson R, Flavell RA (2014) The lock-washer: a reconciliation of the RIG-I activation models. Cell Res 24:645–646. doi:10.1038/cr.2014.58
Park HH (2012) Structural features of caspase-activating complexes. Int J Mol Sci 13:4807–4818. doi:10.3390/ijms13044807
Vande Walle L, Lamkanfi M (2011) Inflammasomes: caspase-1-activating platforms with critical roles in host defense. Front Microbiol 2:3. doi:10.3389/fmicb.2011.00003
Zitvogel L, Kepp O, Galluzzi L, Kroemer G (2012) Inflammasomes in carcinogenesis and anticancer immune responses. Nat Immunol 13:343–351. doi:10.1038/ni.2224
Correa RG, Milutinovic S, Reed JC (2012) Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases. Biosci Rep 32:597–608. doi:10.1042/BSR20120055
Hara H, Iizasa E, Nakaya M, Yoshida H (2010) L-CBM signaling in lymphocyte development and function. J Blood Med 1:93–104. doi:10.2147/JBM.S9772
Thome M (2008) Multifunctional roles for MALT1 in T-cell activation. Nat Rev Immunol 8:495–500. doi:10.1038/nri2338
Beug ST, Cheung HH, LaCasse EC, Korneluk RG (2012) Modulation of immune signalling by inhibitors of apoptosis. Trends Immunol 33:535–545. doi:10.1016/j.it.2012.06.004
Dueber EC, Schoeffler AJ, Lingel A et al (2011) Antagonists induce a conformational change in cIAP1 that promotes autoubiquitination. Science 334:376–380. doi:10.1126/science.1207862
Reikine S, Nguyen JB, Modis Y (2014) Pattern recognition and signaling mechanisms of RIG-I and MDA5. Front Immunol 5:342. doi:10.3389/fimmu.2014.00342
Janssens S, Tinel A (2012) The PIDDosome, DNA-damage-induced apoptosis and beyond. Cell Death Differ 19:13–20. doi:10.1038/cdd.2011.162
Vakifahmetoglu-Norberg H, Zhivotovsky B (2010) The unpredictable caspase-2: what can it do? Trends Cell Biol 20:150–159. doi:10.1016/j.tcb.2009.12.006
de Alba E (2009) Structure and interdomain dynamics of apoptosis-associated speck-like protein containing a CARD (ASC). J Biol Chem 284:32932–32941. doi:10.1074/jbc.M109.024273
Qiao Q, Yang C, Zheng C et al (2013) Structural architecture of the CARMA1/Bcl10/MALT1 signalosome: nucleation-induced filamentous assembly. Mol Cell 51:766–779. doi:10.1016/j.molcel.2013.08.032
Chou JJ, Matsuo H, Duan H, Wagner G (1998) Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment. Cell 94:171–180
Humke EW, Shriver SK, Starovasnik MA, Fairbrother WJ, Dixit VM (2000) ICEBERG: a novel inhibitor of interleukin-1beta generation. Cell 103:99–111
Vaughn DE, Rodriguez J, Lazebnik Y, Joshua-Tor L (1999) Crystal structure of Apaf-1 caspase recruitment domain: an alpha-helical Greek key fold for apoptotic signaling. J Mol Biol 293:439–447. doi:10.1006/jmbi.1999.3177
Chen KE, Richards AA, Caradoc-Davies TT et al (2013) The structure of the caspase recruitment domain of BinCARD reveals that all three cysteines can be oxidized. Acta Crystallogr D Biol Crystallogr 69:774–784. doi:10.1107/S0907444913001558
Jin T, Huang M, Smith P, Jiang J, Xiao TS (2013) The structure of the CARD8 caspase-recruitment domain suggests its association with the FIIND domain and procaspases through adjacent surfaces. Acta Crystallogr Sect F 69:482–487. doi:10.1107/S1744309113010075
Jang TH, Park JH, Park HH (2013) Novel disulfide bond-mediated dimerization of the CARD domain was revealed by the crystal structure of CARMA1 CARD. PLoS One 8:e79778. doi:10.1371/journal.pone.0079778
Yan N, Chai J, Lee ES et al (2005) Structure of the CED-4-CED-9 complex provides insights into programmed cell death in Caenorhabditis elegans. Nature 437:831–837. doi:10.1038/nature04002
Potter JA, Randall RE, Taylor GL (2008) Crystal structure of human IPS-1/MAVS/VISA/Cardif caspase activation recruitment domain. BMC Struct Biol 8:11. doi:10.1186/1472-6807-8-11
Jin T, Curry J, Smith P, Jiang J, Xiao TS (2013) Structure of the NLRP1 caspase recruitment domain suggests potential mechanisms for its association with procaspase-1. Proteins 81:1266–1270. doi:10.1002/prot.24287
Coussens NP, Mowers JC, McDonald C, Nunez G, Ramaswamy S (2007) Crystal structure of the Nod1 caspase activation and recruitment domain. Biochem Biophys Res Commun 353:1–5. doi:10.1016/j.bbrc.2006.11.122
Peisley A, Wu B, Xu H, Chen ZJ, Hur S (2014) Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I. Nature 509:110–114. doi:10.1038/nature13140
Kowalinski E, Lunardi T, McCarthy AA et al (2011) Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 147:423–435. doi:10.1016/j.cell.2011.09.039
Ferrao R, Wu H (2012) Helical assembly in the death domain (DD) superfamily. Curr Opin Struct Biol 22:241–247. doi:10.1016/j.sbi.2012.02.006
Srimathi T, Robbins SL, Dubas RL, Hasegawa M, Inohara N, Park YC (2008) Monomer/dimer transition of the caspase-recruitment domain of human Nod1. Biochemistry 47:1319–1325. doi:10.1021/bi7016602
Liu S, Chen ZJ (2011) Expanding role of ubiquitination in NF-kappaB signaling. Cell Res 21:6–21. doi:10.1038/cr.2010.170
Ver Heul AM, Gakhar L, Piper RC, Subramanian R (2014) Crystal Structure of a Complex of NOD1 CARD and Ubiquitin. PLoS One 9:e104017. doi:10.1371/journal.pone.0104017
Ver Heul AM, Fowler CA, Ramaswamy S, Piper RC (2013) Ubiquitin regulates caspase recruitment domain-mediated signaling by nucleotide-binding oligomerization domain-containing proteins NOD1 and NOD2. J Biol Chem 288:6890–6902. doi:10.1074/jbc.M112.413781
Gack MU, Shin YC, Joo CH et al (2007) TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446:916–920. doi:10.1038/nature05732
Huang S, Zhao L, Kim K, Lee DS, Hwang DH (2008) Inhibition of Nod2 signaling and target gene expression by curcumin. Mol Pharmacol 74:274–281. doi:10.1124/mol.108.046169
Lyss G, Knorre A, Schmidt TJ, Pahl HL, Merfort I (1998) The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappaB by directly targeting p65. J Biol Chem 273:33508–33516
Bielig H, Velder J, Saiai A et al (2010) Anti-inflammatory arene–chromium complexes acting as specific inhibitors of NOD2 signalling. ChemMedChem 5:2065–2071. doi:10.1002/cmdc.201000320
Zhao L, Kwon MJ, Huang S et al (2007) Differential modulation of Nods signaling pathways by fatty acids in human colonic epithelial HCT116 cells. J Biol Chem 282:11618–11628. doi:10.1074/jbc.M608644200
Correa RG, Khan PM, Askari N et al (2011) Discovery and characterization of 2-aminobenzimidazole derivatives as selective NOD1 inhibitors. Chem Biol 18:825–832. doi:10.1016/j.chembiol.2011.06.009
Magnuson G, Khan P, Yuan H et al (2010) High Throughput Screening Assays for NOD1 Inhibitors - Probe 2. Probe Reports from the NIH Molecular Libraries Program, Bethesda
Palacios-Rodriguez Y, Garcia-Lainez G, Sancho M, Gortat A, Orzaez M, Perez-Paya E (2011) Polypeptide modulators of caspase recruitment domain (CARD)-CARD-mediated protein-protein interactions. J Biol Chem 286:44457–44466. doi:10.1074/jbc.M111.255364
Moreno L, Gatheral T (2013) Therapeutic targeting of NOD1 receptors. Br J Pharmacol 170:475–485. doi:10.1111/bph.12300
Gatheral T, Reed DM, Moreno L et al (2012) A key role for the endothelium in NOD1 mediated vascular inflammation: comparison to TLR4 responses. PLoS One 7:e42386. doi:10.1371/journal.pone.0042386
Rickard DJ, Sehon CA, Kasparcova V et al (2013) Identification of benzimidazole diamides as selective inhibitors of the nucleotide-binding oligomerization domain 2 (NOD2) signaling pathway. PLoS One 8:e69619. doi:10.1371/journal.pone.0069619
Saiai A, Bielig H, Velder J et al (2012) Hydrophenalene-Cr(CO)(3) complexes as anti-inflammatory agents based on specific inhibition of NOD2 signalling: a SAR study. Medchemcomm 3:1377–1385. doi:10.1039/C2md20221b
Jun JC, Cominelli F, Abbott DW (2013) RIP2 activity in inflammatory disease and implications for novel therapeutics. J Leukoc Biol 94:927–932. doi:10.1189/jlb.0213109
Tigno-Aranjuez JT, Asara JM, Abbott DW (2010) Inhibition of RIP2′s tyrosine kinase activity limits NOD2-driven cytokine responses. Genes Dev 24:2666–2677. doi:10.1101/gad.1964410
Fulda S (2012) Novel promising IAP antagonist on the horizon for clinical translation. J Med Chem 55:4099–4100. doi:10.1021/jm300475b
Ndubaku C, Varfolomeev E, Wang L et al (2009) Antagonism of c-IAP and XIAP proteins is required for efficient induction of cell death by small-molecule IAP antagonists. ACS Chem Biol 4:557–566. doi:10.1021/cb900083m
LaCasse EC, Mahoney DJ, Cheung HH, Plenchette S, Baird S, Korneluk RG (2008) IAP-targeted therapies for cancer. Oncogene 27:6252–6275. doi:10.1038/onc.2008.302
Gaither A, Porter D, Yao Y et al (2007) A Smac mimetic rescue screen reveals roles for inhibitor of apoptosis proteins in tumor necrosis factor-alpha signaling. Cancer Res 67:11493–11498. doi:10.1158/0008-5472.CAN-07-5173
Varfolomeev E, Blankenship JW, Wayson SM et al (2007) IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell 131:669–681. doi:10.1016/j.cell.2007.10.030
Vince JE, Wong WW, Khan N et al (2007) IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 131:682–693. doi:10.1016/j.cell.2007.10.037
Bai L, Chen W, Wang X, Ju W, Xu S, Lin Y (2009) Attenuating Smac mimetic compound 3-induced NF-kappaB activation by luteolin leads to synergistic cytotoxicity in cancer cells. J Cell Biochem 108:1125–1131. doi:10.1002/jcb.22346
Park CM, Sun C, Olejniczak ET et al (2005) Non-peptidic small molecule inhibitors of XIAP. Bioorg Med Chem Lett 15:771–775. doi:10.1016/j.bmcl.2004.11.010
Infante JR, Dees EC, Olszanski AJ et al (2014) Phase I Dose-Escalation Study of LCL161, an Oral Inhibitor of Apoptosis Proteins Inhibitor, in Patients With Advanced Solid Tumors. J Clin Oncol 32:3103–3110. doi:10.1200/JCO.2013.52.3993
Brunckhorst MK, Lerner D, Wang S, Yu Q (2012) AT-406, an orally active antagonist of multiple inhibitor of apoptosis proteins, inhibits progression of human ovarian cancer. Cancer Biol Ther 13:804–811. doi:10.4161/cbt.20563
Okuhira K, Ohoka N, Sai K et al (2011) Specific degradation of CRABP-II via cIAP1-mediated ubiquitylation induced by hybrid molecules that crosslink cIAP1 and the target protein. FEBS Lett 585:1147–1152. doi:10.1016/j.febslet.2011.03.019
Swinney DC, Xu YZ, Scarafia LE et al (2002) A small molecule ubiquitination inhibitor blocks NF-kappa B-dependent cytokine expression in cells and rats. J Biol Chem 277:23573–23581. doi:10.1074/jbc.M200842200
Vicent MJ, Perez-Paya E (2006) Poly-l-glutamic acid (PGA) aided inhibitors of apoptotic protease activating factor 1 (Apaf-1): an antiapoptotic polymeric nanomedicine. J Med Chem 49:3763–3765. doi:10.1021/jm060458x
Mondragon L, Galluzzi L, Mouhamad S et al (2009) A chemical inhibitor of Apaf-1 exerts mitochondrioprotective functions and interferes with the intra-S-phase DNA damage checkpoint. Apoptosis Int J Program Cell Death 14:182–190. doi:10.1007/s10495-008-0310-x
Wannamaker W, Davies R, Namchuk M et al (2007) (S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoy l)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1beta and IL-18. J Pharmacol Exp Ther 321:509–516. doi:10.1124/jpet.106.111344
Boost KA, Hoegl S, Hofstetter C et al (2007) Targeting caspase-1 by inhalation-therapy: effects of Ac-YVAD-CHO on IL-1 beta, IL-18 and downstream proinflammatory parameters as detected in rat endotoxaemia. Intensive Care Med 33:863–871. doi:10.1007/s00134-007-0588-0
Kast RE (2008) Ritonavir and disulfiram may be synergistic in lowering active interleukin-18 levels in acute pancreatitis, and thereby hasten recovery. JOP 9:350–353
Pelegrin P, Surprenant A (2009) Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphates. EMBO J 28:2114–2127. doi:10.1038/emboj.2009.163
Lamkanfi M, Mueller JL, Vitari AC et al (2009) Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J Cell Biol 187:61–70. doi:10.1083/jcb.200903124
Coll RC, Robertson A, Butler M, Cooper M, O’Neill LA (2011) The cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes. PLoS One 6:e29539. doi:10.1371/journal.pone.0029539
Thacker JD, Balin BJ, Appelt DM et al (2012) NLRP3 inflammasome is a target for development of broad-spectrum anti-infective drugs. Antimicrob Agents Chemother 56:1921–1930. doi:10.1128/AAC.06372-11
Acknowledgments
This work is supported by Ministry of Science and Technology Grant MOST 101-2311-B-006-008-MY3 and Academia Sinica Thematic Research Program AS-102-TP-B14-1 (to Y.C.L.), and Ministry of Science and Technology Grant MOST 101-2320-B-001-034-MY3 and Academia Sinica Thematic Research Program AS-102-TP-B14-2 (to S.C.L.), and Academia Sinica Postdoc Fellowship (to C.Y.Y.).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Kao, WP., Yang, CY., Su, TW. et al. The versatile roles of CARDs in regulating apoptosis, inflammation, and NF-κB signaling. Apoptosis 20, 174–195 (2015). https://doi.org/10.1007/s10495-014-1062-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10495-014-1062-4